Overlooked Therapy Revolutionizing Sickle Cell Care in Africa
Elijah TobsNa Elijah Tobs
Afya
6 Mei 2026 • 9:33 PM
5m5 min read
Imethibitishwa
Chanzo: Pexels
Ufahamu wa Msingi
Sickle cell disease affects 7.7 million worldwide, with over 75% of cases in Africa and 300,000 annual births in sub-Saharan Africa. Red blood cell exchange, an underutilized therapy, lowers sickle hemoglobin, prevents strokes, manages pain crises, and offers a repeatable alternative to bone marrow transplants without needing donors. Recent successful procedures highlight its potential to reduce hospitalizations and improve quality of life.
Kama mwanzilishi na sauti kuu ya utafiti katika Kodawire, Elijah Tobs ana uzoefu wa zaidi ya miaka 15 katika kuchambua mifumo tata ya kijiopolitiki na kifedha. Kazi yake inazingatia utawala wa kimaadili wa teknolojia zinazoibuka, miundo inayobadilika ya fedha za kimataifa, na mustakabali wa elimu katika ulimwengu wa kidijitali. Akiwa mtetezi mkubwa wa uandishi wa habari wenye usahihi wa hali ya juu, alianzisha Kodawire kuwa mahali pa akili ya kina. Akijitenga na asili ya muda mfupi ya vichwa vya habari vya kisasa, Kodawire hutoa maarifa ya kudumu na yaliyothibitishwa yanayochochea mabadiliko.
Red Blood Cell Exchange: Njia Iliyepuuzwa ya Kuokoa Maisha kwa Sickle Cell Disease barani Afrika
Seli nyekundu zenye umbo la sickle chini ya mikroskopu (Chanzo: Leo Freire kupitia Pexels)
Kwa watu wanaoishi na sickle cell disease, matumaini mara nyingi hupimwa kwa ushindi mdogo: mwezi bila mgogoro wa maumivu, usiku mdogo zaidi katika vyumba vya dharura, na uhuru wa kupanga maisha bila hofu ya mara kwa mara ya kipindi kinachofuata. Kwa wazazi na wapendwa, matumaini inamaanisha kuona wapendwa wakipunguza mateso na kuishi kikamilifu zaidi.
Sickle cell disease ni moja ya matatizo ya damu yanayorithishwa mengi duniani kote, lakini hayatibiwi vizuri, hasa barani Afrika, ambapo mzigo ni mkubwa zaidi. Shirika la Afya Duniani linakadiria watu milioni 7.7 duniani kote wanaoishi na sickle cell disease, na idadi kubwa zaidi iko barani Afrika Kusini-mwa-Sahara, ongezeko la 40% tangu 2000. Hali hii husababisha vifo zaidi ya 300,000 kila mwaka.
Data indicate more than 75% of babies born with sickle cell disease worldwide are born on the African continent. Approximately 400,000 babies are born with sickle cell disease globally each year, with more than 300,000 in sub-Saharan Africa. Nigeria accounts for around 150,000 of these newborns annually, with prevalence projected to rise by 2050. Millions more in the African diaspora, including the United States, United Kingdom, Caribbean, and Europe, manage the lifelong impact.
Ufikiaji wa matibabu ya hali ya juu bado ni mdogo. Wagonjwa mara nyingi huambiwa kuwa utunzaji muhimu unapatikana nje ya nchi au kwamba upandishaji wa uboho wa mfupa ndio suluhu pekee, hivyo kuleta kufadhaika badala ya faraja.
Red Blood Cell Exchange: Tiba Iliyothibitishwa, Inayotumika Kidogo
Red blood cell exchange kwa kutumia teknolojia ya apheresis ya hali ya juu (Chanzo: Roger Brown kupitia Pexels)
Red blood cell exchange ni moja ya tiba zenye ufanisi zaidi lakini zinazotumika kidogo kwa sickle cell disease. Mwongozo wa kimatibabu kutoka American Society of Haematology unaitambua kwa kuzuia kiharusi, kusimamia mgogoro mkali wa maumivu, na matatizo yanayohitaji maisha kama acute chest syndrome.
Katika African Medical Centre of Excellence (AMCE), timu zinatoa tiba za hali ya juu, ikiwa ni pamoja na red blood cell exchange. Kituo hivi hivi karibuni kimekamilisha utaratibu wake wa kwanza kwa kutumia mashine ya Terumo Optia kwa mgonjwa aliye na sickle cell anaemia na maumivu ya muda mrefu. Utaratibu ulihusisha kuondoa seli nyekundu za mgonjwa zenye sickle na kuzibadilisha na seli nyekundu za haemoglobin AA. Mgonjwa amebaki bila maumivu tangu wakati huo, akionyesha uwezo wa kubadilisha wa tiba hii.
Red blood cell exchange hupunguza haraka uwiano wa haemoglobin ya sickle, inaboresha mtiririko wa damu, na inapunguza hatari ya uharibifu wa viungo unaoendelea. Inatumika kwa maumivu makali ya mfupa, maandalizi ya upandishaji wa seli shina, parasitaemia kali ya malaria, na sumu ya kaboni monoksidi. Kwa kubadilisha seli nyekundu zisizofaa na zenye afya, inashughulikia moja kwa moja fisiolojia ya ugonjwa.
Badala Inayopatikana Zaidi ya Upandishaji wa Uboho wa Mfupa
Tiba inayopatikana badala ya upandishaji unaohitaji rasilimali nyingi (Chanzo: Marta Branco kupitia Pexels)
Upandishaji wa uboho wa mfupa ndio tiba pekee iliyothibitishwa ya kurekebisha lakini inazuiliwa na upatikanaji wa mtoaji anayefaa na ni ghali na inahitaji rasilimali nyingi, isiyoweza kufikiwa na wengi. Usimamizi bora wa muda mrefu ni muhimu kwa kuboresha ubora wa maisha na kupunguza matatizo.
Tofauti na upandishaji wa uboho wa mfupa, red blood cell exchange inaweza kurudiwa, haihitaji mtoaji aliyelingana, na inapatikana zaidi katika AMCE kwa wagonjwa nchini Nigeria na kote barani Afrika. Inapofanywa mara kwa mara, inapunguza hatari ya kiharusi sana kwa watoto na mara ya mgogoro mkali wa maumivu kwa watu wazima.
Kwa wagonjwa wasiostahiki upandishaji au wanaotafuta hospitalizisheni ndogo na maumivu mdogo, red blood cell exchange inatoa utulivu na heshima.
Wito kwa Wagonjwa, Wafamilia, na Jamii ya Afya
Wafamilia wakipata matumaini katika utunzaji wa hali ya juu wa ndani (Chanzo: Tima Miroshnichenko kupitia Pexels)
Wagonjwa wanaohitaji red blood cell exchange wana chaguo katika AMCE, si kwa sickle cell disease pekee bali pia kwa parasitaemia kali ya malaria au sumu ya kaboni monoksidi. Wafamilia wanaweza kupata utunzaji wa mtaalamu karibu na nyumbani kwa mipango iliyobinafsishwa.
Sickle cell disease inachangia mzigo mkubwa barani Afrika na diaspora yake, ikichangia mateso yanayoweza kuzuiliwa, hospitalizisheni, na vifo vya mapema. Kwa kuanzisha red blood cell exchange, AMCE inabadilisha ukweli huu, ikionyesha kuwa hatua za hali ya juu zinawezekana ndani ya Afrika. Hii inapanua upatikanaji, inarudisha matumaini, inaboresha ubora wa maisha, na inawapa wagonjwa na wafamilia nguvu ya kusimamia matatizo ya damu kwa heshima na ujasiri.
Red blood cell exchange removes sickled red cells and replaces them with healthy haemoglobin AA red cells, rapidly lowering sickle haemoglobin, improving blood flow, and reducing pain crises, stroke risk, and organ damage.
At the African Medical Centre of Excellence (AMCE) in Nigeria, where the first procedure using the Terumo Optia machine was recently completed on a sickle cell patient.
Unlike bone marrow transplantation, which requires a matched donor and is costly, red blood cell exchange is repeatable, needs no donor, and is more accessible for managing severe symptoms.
Patients like the one at AMCE have remained pain-free since the procedure, with reduced frequency of severe pain crises and stroke risk when performed regularly.
It is used for refractory bone pain, preparation for stem cell transplantation, severe malaria parasitaemia, and carbon monoxide poisoning.
Ushiriki Amilifu
Je, habari hii imekusaidia?
Jiunge na Majadiliano
Mawazo 0
Timu ya Uhariri • Swali la Leo
"Could red blood cell exchange change sickle cell care where you live?"
